As of May 8, 2025, the Novanta stock's P/E ratio is 62.52. This results from the current EPS of $1.95 and stock price of $121.91. The PE ratio has decreased by 29% from the past four quarters average of 88.0.
The PE ratio of Novanta has averaged 70.76 over the last ten years. The current price-to-earnings ratio of 62.52 is 12% less than the historical average. In the past ten years, NOVT's PE ratio reached its highest point in the Mar 2018 quarter at 153.38, when the stock price was $52.15 and the EPS was $0.34. The lowest point was recorded in the Dec 2015 quarter, when it reached 13.22 with a price of $13.62 and an EPS of $1.03.
Maximum annual increase: 258.47% in 2013
Maximum annual decrease: -47.4% in 2022
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 85.83 | 3.46% | $152.77 | $1.78 |
2023 | 82.96 | 27.01% | $168.41 | $2.03 |
2022 | 65.32 | -47.4% | $135.87 | $2.08 |
2021 | 124.18 | 33.4% | $176.33 | $1.42 |
2020 | 93.09 | 22.1% | $118.22 | $1.27 |
2019 | 76.24 | 76.69% | $88.44 | $1.16 |
2018 | 43.15 | -1.62% | $63 | $1.46 |
2017 | 43.86 | 31.59% | $50 | $1.14 |
2016 | 33.33 | 152.12% | $21 | $0.63 |
2015 | 13.22 | N/A | $13.62 | $1.03 |
2014 | N/A | N/A | $14.72 | -$0.7 |
2013 | 53.52 | 258.47% | $11.24 | $0.21 |
2012 | 14.93 | 26.96% | $8.66 | $0.58 |
2011 | 11.76 | N/A | $10.23 | $0.87 |
2010 | N/A | N/A | $10.58 | -$0.03 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 66.19 | -22.88% | $129.08 | $1.95 |
Dec 2024 | 85.83 | -18.78% | $152.77 | $1.78 |
Sep 2024 | 105.67 | 12.08% | $176.47 | $1.67 |
Jun 2024 | 94.28 | 4.12% | $163.11 | $1.73 |
Mar 2024 | 90.55 | 9.15% | $174.77 | $1.93 |
Dec 2023 | 82.96 | 22.04% | $168.41 | $2.03 |
Sep 2023 | 67.98 | -20.61% | $143.44 | $2.11 |
Jun 2023 | 85.63 | 10.88% | $184.1 | $2.15 |
Mar 2023 | 77.23 | 18.23% | $159.09 | $2.06 |
Dec 2022 | 65.32 | 15.22% | $135.87 | $2.08 |
Sep 2022 | 56.69 | -15.13% | $115.65 | $2.04 |
Jul 2022 | 66.8 | -22.91% | $119.58 | $1.79 |
Apr 2022 | 86.65 | -30.22% | $141.24 | $1.63 |
Dec 2021 | 124.18 | 12.59% | $176.33 | $1.42 |
Oct 2021 | 110.29 | -0.44% | $153.3 | $1.39 |
Currently, NOVT's PE ratio is lower than the 3, 5 and 10-year averages.
Stock name | PE ratio | Market cap |
---|---|---|
NOVT Novanta Inc | 62.52 | $4.39B |
OBIO Orchestra BioMed Holdings Inc | N/A | $109.96M |
OM Outset Medical Inc | N/A | $57.06M |
NOVT stock has a price to earnings ratio of 62.52 as of May 8, 2025.
The average PE ratio for NOVT stock over the past 3 years is 78.76.
The average PE ratio for NOVT stock over the past 5 years is 88.1.
The highest quarterly PE ratio in the last ten years has been 153.38 and it was in the Mar 2018 quarter.
NOVT's price to earnings ratio is currently 12% below its 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (May 8, 2025), Novanta's stock price is $121.91. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $1.95. Therefore, Novanta's price to earnings ratio for today is 62.52. PE RATIO(62.52) = STOCK PRICE($121.91) / TTM EPS($1.95)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.